Skip to content

Impact of Consumption of Orange-fleshed Sweet Potatoes on the Vitamin A Status of Bangladeshi Women of Reproductive Age

Efficacy of Daily Consumption of Sweet Potatoes for Increasing Total Body Vitamin A Pool Size, and the Effect of Consumption of Sweet Potatoes on Iron and Zinc Absorption in Bangladeshi Women of Reproductive Age

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00453648
Enrollment
130
Registered
2007-03-29
Start date
2006-03-31
Completion date
2009-12-31
Last updated
2017-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin A Deficiency

Keywords

stable isotopes, vitamin A, beta-carotene, orange-fleshed sweet potatoes, iron, zinc, absorption, bioavailability, vitamin A equivalency, Bangladesh, women

Brief summary

The primary purpose of this study is to determine whether daily consumption of orange-fleshed sweet potatoes increases the vitamin A status of Bangladeshi women of reproductive age. Secondary purposes of the study are to determine whether consumption of orange-fleshed sweet potatoes has an effect on the intestinal absorption of dietary iron or dietary zinc in Bangladeshi women of reproductive age.

Detailed description

Biofortification of plant source foods is a promising strategy for increasing dietary vitamin A intake and vitamin A status in populations at risk of deficiency. The primary purposes of this study are: 1. to assess the efficacy of daily consumption of boiled or fried orange-fleshed sweet potatoes (OFSP) for increasing the vitamin A status of non-pregnant, non-lactating Bangladeshi women, and 2. to estimate the relative vitamin A equivalency of beta-carotene from the two different preparations of OFSP (boiled or fried). Secondary purposes are to assess the effect of daily consumption of OFSP on intestinal absorption of iron and zinc. Specifically, 120 non-pregnant, non-lactating women at risk of vitamin A deficiency will be randomly assigned to one of the following 4 treatment groups to receive, 600 micrograms RAE/d, 6 d/wk, for 60 days as either: 1. boiled OFSP 2. fried OFSP 3. retinyl palmitate, or 0 micrograms RAE/d as white-fleshed sweet potato (WFSP) The paired stable isotope dilution technique will be used to estimate total body vitamin A pool size before and after 60-days of supplementation. The efficacy of consumption of OFSP will be assessed by comparing the mean change in vitamin A pool size in the OFSP groups to the mean change in vitamin A pool size in the negative control group (WFSP group). Relative vitamin A equivalency factors will be estimated by comparing the mean change in vitamin A pool size in the OFSP groups with the mean change in vitamin A pool size in the retinyl palmitate group. Intestinal iron absorption and iron status will be assessed before and after the 60-day supplementation period in a subset of women (n=50); and intestinal zinc absorption and zinc status will be assessed after the 60-day supplementation period (n=50). Intestinal absorption of iron and zinc will be compared by treatment group to determine whether consumption of OFSP has any effect on iron or zinc absorption in these women.

Interventions

OTHERWhite-fleshed sweet potatoes
OTHEROrange-fleshed sweet potatoes (boiled)
OTHEROrange-fleshed sweet potatoes (fried)
OTHERWFSP and capsule of retinyl palmitate

Sponsors

International Centre for Diarrhoeal Disease Research, Bangladesh
CollaboratorOTHER
University of California, Davis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Serum retinol concentration \< 1.12 umol/L * Serum C-reactive protein concentration \< 10 mg/L

Exclusion criteria

* Pregnant * Lactating * Diarrhea within past week * Severe anemia (\< 9g Hb/dL) * Symptoms of nightblindness * Clinical symptoms of xerophthalmia * Chronic disease

Design outcomes

Primary

MeasureTime frame
Total body vitamin A pool size3 years

Secondary

MeasureTime frame
Iron absorption3 years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026